Dr. Mark Okamoto is the Dean of the Department of Pharmacy. He also serves as Chief Academic Officer for Georgia Campus - Philadelphia College of Osteopathic Medicine.
1989 (PI). Tissue penetration of cefepime into human appendix. Bristol-Myers Squibb:
1990 (PI): Penetration of cefepime into gallbladder tissue in patients undergoing cholecystectomy. Bristol-Myers Squibb
1990 (PI). A cost benefit analysis of cefepime versus gentamicin/clindamycin in acute cholecystitis. Bristol -Myers Squibb:
1991 (Co-I). Cost-effectiveness of transdermal delivery systems for antihypertensive medication. Boehringer Ingelheim Pharmaceuticals, Inc.
1991 (Co-I). Determination of fluconazole in human serum by solid phase extraction and reversed phase HPLC. Glaxo Pharmaceuticals
1992 (PI). Pharmacoeconomic evaluation of a pharmacist managed hypertension clinic. The Upjohn Company
1994 (PI). The use of Alpha Adrenergic Blockers in the Treatment of Benign Prostatic Hypertrophy. Kaiser Permanente Regional Research Grant.
1997 (PI). Socioeconomic evaluation of fluoxetine, paroxetine and sertraline in a managed care setting. Eli Lilly and Company:
2003 (Co-PI). Evaluation of outcomes of community based disease state management programs: Asthma & Diabetes. Community Pharmacy Foundation
2009 (Co-I). Multi-scale analysis and knowledge structuring for natural products. National Science Foundation – Science and technology centers
Annals of Pharmacotherapy (2003-present)
Chair – Medication Therapy Management section (2011-present)
Current Medicinal Chemistry – Anti Infective Agents (2000-present)
International Society for Pharmacoeconomic & Outcomes Research (ISPOR) Pharmacoeconomics
Expert Review of Pharmacoeconomics & Outcomes Research
Annals of Pharmacotherapy
Journal of Pharmacy Technology
Clinical Pharmacy American Journal of Health-System Pharmacy
Clinical Drug Investigation
American Journal of Respiratory Medicine
Journal of Managed Care Pharmacy
Journal of Clinical Anesthesia